Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY: TMO )

593.51 -5.10 (-0.85%)
Streaming Delayed Price Updated: 9:34 AM EDT, Oct 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
7 Contrarian Biotech Stocks to Consider Amid Sector Weakness
Although the healthcare innovation space has struggled recently, these contrarian biotech stocks now offer compelling discounts. 
Via InvestorPlace
Ray Dalio's Bridgewater Makes Waves: Q4 Unveils Strategic Shifts With New Investments, Sector Expansion In Tech
Bridgewater Associates, founded by Ray Dalio, made notable changes to its portfolio in Q4 2023. New bets, exits, increased stakes offer insights into its investment strategy. 
Via Benzinga
Buy the Dip: 3 Oversold Stocks Poised for Big Gains
Discover how these oversold stocks to buy point towards potential fast gains while their fundamentals support potentially further growth. 
Via InvestorPlace
TransDigm, West Pharmaceutical, Thermo Fisher Scientific And A Tech Company On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Steve Weiss of Short Hills Capital Partners named TransDigm Group Incorporated (NYSE: TDG), which is scheduled to release 
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $15,000 Today
Via Benzinga
Thermo Fisher Scientific: Q4 Earnings Insights
Via Benzinga
A Preview Of Thermo Fisher Scientific's Earnings
Via Benzinga
RBC Capital Maintains Outperform Rating for Thermo Fisher Scientific: Here's What You Need To Know
Via Benzinga
Biotech And Medtech Portfolio Notes On A Fed Day
The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23% 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Buy Alert: 3 Stocks Sitting in the Sweet Spot
They say timing is everything, so investors will want to take advantage of buying these stocks now instead of waiting. 
Via InvestorPlace
Nasdaq, S&P 500 Slip Ahead Of Fed Meeting, Regional Banks Sink After NYCB Disappoints: What's Driving Markets Wednesday?
Nasdaq down 1.4%, S&P 500 down 0.9%, Dow up: Volatile day on Wall Street as tech stocks react to disappointing earnings ahead of Fed meeting. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Market Whales and Their Recent Bets on TMO Options
Via Benzinga
Breaking Down Thermo Fisher Scientific: 5 Analysts Share Their Views
Via Benzinga
Thermo Fisher Scientific (TMO) Q4 2023 Earnings Call Transcript
TMO earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Medical Equipment Maker Thermo Fisher Scientific Clocks 7% Decline In Q4 Organic Sales, Issues Subdued Annual Outlook
"Thermo Fisher Scientific surpasses Q4 revenue expectations at $10.89B, down 5% YoY. Analytical Instruments Segment rises 8.5%. Financial highlights and 2024 revenue guidance. 
Via Benzinga
Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's Presser
The record run of the market faces risk as the big tech earnings season got off to a negative start, casting cloud on profit outlook. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Peering Into Thermo Fisher Scientific's Recent Short Interest
Via Benzinga
Thermo Fisher Scientific Inc. (NYSE: TMO) is a Leading Gainer in 1/9 Morning Trading
Via Investor Brand Network
Thermo Fisher Scientific Unusual Options Activity
Via Benzinga
Three Stocks To Diversify Beyond The Magnificent Seven In 2024
Via Talk Markets
Earnings Scheduled For January 31, 2024
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion. 
Via Benzinga
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2023 Results
From Thermo Fisher Scientific Inc.
Via Business Wire
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END 
Via FinancialNewsMedia
$100 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
From FN Media Group LLC
Via GlobeNewswire
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
From Thermo Fisher Scientific Inc.
Via Business Wire
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Here's How Much $1000 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth Today
Via Benzinga
Thermo Fisher Scientific to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024
From Thermo Fisher Scientific Inc.
Via Business Wire
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, January 31, 2024
From Thermo Fisher Scientific Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.